使用丁螺环酮治疗非药物性磨牙症：约 4 例报告。
Use of Buspirone in the Treatment of Nonpharmacological Bruxism: About 4 Cases.
机构信息
Positive University Curitiba.
Research Unit, Hospital Pequeno Principe.
出版信息
Clin Neuropharmacol. 2021;44(6):247-249. doi: 10.1097/WNF.0000000000000486.
OBJECTIVE
The aim of the study was to describe the efficacy of buspirone in controlling nonpharmacological awake and sleep bruxism.
METHODS
Four cases of nonpharmacological awake and sleep bruxism, one of them with a 20-year-long history, in which buspirone succeeded to control bruxism, are described and discussed.
RESULTS
Two of the 4 cases had sleep bruxism, and the other 2 cases had sleep and awake bruxism. Besides anxiety, no other predisposing condition was identified. Buspirone was effective in reducing bruxism symptoms in the 4 cases. Mean percentage of bruxism reduction after buspirone was ranked as 65% by subjects.
CONCLUSIONS
In this small series of cases, buspirone proved effective in the control of nonpharmacological awake and sleep bruxism.
目的
研究旨在描述丁螺环酮控制非药物性清醒和睡眠磨牙症的疗效。
方法
描述并讨论了 4 例非药物性清醒和睡眠磨牙症病例，其中 1 例有 20 年病史，丁螺环酮成功控制了磨牙症。
结果
4 例中有 2 例为睡眠磨牙症，另外 2 例为睡眠和清醒磨牙症。除了焦虑，没有发现其他诱发因素。丁螺环酮在 4 例中有效减少磨牙症症状。在 subjects 中，磨牙症减少的平均百分比为 65%。
结论
在本小系列病例中，丁螺环酮在控制非药物性清醒和睡眠磨牙症方面证明是有效的。
Zotero 插件